Abstract 1307: Inhibition of ERK by LY3214996 augments nab-paclitaxel and gemcitabine combination chemotherapy efficacy in preclinical models of pancreatic cancer

Authors: Shripad V. Bhagwat, Wenjuan Wu, Baohui Zhao, Weihua Shen, Lisa Kindler, Jennifer Stephens, Jason Manro, William McMillen, Sajan Joseph, Sheng-Bin Peng, Ramon V. Tiu

Published: 2019-08-07

DOI: 10.1158/1538-7445.am2019-1307

Source: Full article